Upload
moses-ellis
View
214
Download
1
Embed Size (px)
Citation preview
Cancer Diagnostic Pathway Audit Report
North of England Cancer Network
Title North of England Cancer Diagnostic Pathway Audit Report
Reference Final Report National GP Audit NECN
Version Release 2 Final V04
Date 22/11/10
Author Parry Lothian Consultancy
Change History
6/10/10 – V01 For initial discussions with GP Cancer Leads
4/11/10 – V02 Final Draft for comments to GP Cancer Leads
12/11/10 – V03 Final Report for submission to client
22/11/2010 – V04 Final Report Release 2 - following client discussion
North of England Cancer Network Cancer Diagnostic Pathway Audit 2
ContentsContents
1. Introduction2. Context and Background3. Methodology
• The Approach• Practice Participation• The Participating Practices• Practice Locations and Population• Tools, Parameters and Timelines
4. The Audit Process5. Findings
• Overview• Key Factors• Base Information• Attendances• Referral Detail and Processes• Diagnosis• Possible Avoidable Delays
6. Practice Learning and Actions 7. Recommendations8. Acknowledgements
North of England Cancer Network Cancer Diagnostic Pathway Audit 3
IntroductionIntroduction
North of England Cancer Network Cancer Diagnostic Pathway Audit 4
IntroductionIntroduction
This report describes the process and outcomes from the North of England Cancer Networks’ participation in the National GP Cancer Audit. This is the third element of work
progressed under the umbrella of National Awareness and Early Diagnosis Initiative (NAEDI).
The report highlights the specific findings, the issues raised and the local actions taken to improve specific elements of the care pathway both at practice level and within interfaces
with secondary care.
It makes recommendations on the transference of learning, local communication and further work that will require action.
Initial presentation in Primary Care
Reducing the time delay and waste in the patient journey to support earlier cancer diagnosis
Diagnosis
The second project on NAEDI The third project on NAEDI – the subject of this report
Cancer in Primary Care - the initial NAEDI work
5North of England Cancer Network Cancer Diagnostic Pathway Audit
Context and BackgroundContext and Background
North of England Cancer Network Cancer Diagnostic Pathway Audit 6
Context and BackgroundContext and Background
Cancer in Primary Care -
the initial NAEDI work
The second project on
NAEDI
As part of the NAEDI to promote timely diagnosis of cancer, a national significant event audit of cancer diagnosis in primary care was commissioned and reported in 2009. This audit in the north east of England was carried out by a collaboration between Durham, Glasgow and Dundee Universities. This primary care audit study was specifically to gain insight into the events that surround the diagnostic process for two groups in cancer (lung cancer and cancer affecting teenagers and young adults). The study demonstrated appropriate recognition and referral for both cancer groups. Where recognition had taken longer there were often reasonable explanations – for lung cancer these related to chest x-rays reported as normal, patient choice factors or presentations complicated by co-morbidity. There was also system and practitioner issues and the use of guidelines highlighted in the findings. The full report can be found on www.cancernorth.nhs.uk
From the initial study above a further project was initiated by NHS County Durham and Darlington . This project was to work more closely with primary care to identify, analyse and find solutions to issues that prevented quick diagnosis as identified in the significant event audit (SEA).As NHS North East were already well advanced in their application of the Virginia Mason Production System the proposal suggested that this vehicle was used to carry out this ‘new ‘work building on from and using the initial findings for lung cancer.This proposal was supported by the National Cancer Action Team and was extended across the Cancer Network to include NHS South of Tyne and Wear. Funding from the National Cancer Action was made available and planning began in November 2009. The initial report on this work was completed in April 2010.Durham University, School of Medicine and Health has evaluated the Virginia Mason Production System as it is applied to the primary care work. This study will be available later in 2010.
7North of England Cancer Network Cancer Diagnostic Pathway Audit
Context and Background continuedContext and Background continued
The third project on NAEDI – the subject of this
report
The North of England Cancer Network are now building upon the previous NAEDI work by participating in the National GP Audit developed by the Royal College of General Practitioners and the National Cancer Action Team. An audit tool supports this work and is called the Diagnostic Pathway Template.
The aim of this audit is
•To identify any delays in patient pathways•To identify any potential groups of patients or tumour types which are particularly vulnerable to delay•To use the findings to plan interventions to improve early diagnosis across the North of England Cancer Network•To ensure that the findings inform the commissioning intentions for each PCT•To inform and supply information to the National Database
Overall the aim is to build on current good practice and inform service improvements thereby ensuring that individuals with symptoms suspicious of cancer are referred appropriately and early.
North of England Cancer Network Cancer Diagnostic Pathway Audit 8
MethodologyMethodology
North of England Cancer Network Cancer Diagnostic Pathway Audit 9
Phase 2 – Planning and Recruiting Phase 3 – Date Collection and Cleansing
Phase 4 – Data Analysis and ReportingPhase 1- Project Initiation
Audit by North of England Cancer Network and Network Primary Care Group.
Aims and objectives of the audit agreed.
Audit parameters agreed.
External Consultant support agreed and recruited.
Timelines and GP practice responsibilities agreed
Scope of practice participants agreed.
Remuneration for practices agreed.
Project Group and Activity Plan developed.
Briefing Pack and Practice agreement developed.
GP Cancer Leads identify and recruited practices
Each participating practice was given from June to October 2010 to complete the audit template.
The records were validated and the data cleansed and amendments agreed with each practice audit lead.
Each practice was given a further month to produce a report of their findings and any action taken.
The data was analysed and the main findings agreed with the GP Cancer Leads.
Guidance supplied by Professor Greg Rubin, Wolfson Institute, University of Durham
The report developed and signed off in November 2010.
Terms of Reference for Project Group.
Audit parameters and timelines.
Project Plan
Briefing pack for participating practices and GP Cancer Leads
Completed , consolidated and validated audit template
A practice report from each participating practice
Data analysis
Final Report
Methodology – The ApproachMethodology – The Approach
10North of England Cancer Network Cancer Diagnostic Pathway Audit
Methodology – Practice ParticipationMethodology – Practice Participation
The Practices
GP Practice remuneration
GP Practice roles and responsibilities
GP Practice participation
24 GP Practices were recruited from across the five localities in the NECN . There was no systematic recruitment based on agreed criteria. Practices were approached based on the knowledge they would cooperate, they would find the capacity to participate and would meet the timelines.
The Practices were asked to identify a lead for the practice who would coordinate the completion of the audit and ensure the timelines were met. Each Practice also agreed to conduct a practice meeting/learning event to discuss the audit, identify key areas for improvement and produce an action plan for implementation. This report was shared with the Cancer Network and formed part of the audit process.
Each practice was to receive £500 + £30 per patient record audited, completed and validated. Payment was made retrospectively upon completion of the template with validated records and the production of their practice report template.
Participating Practices varied in size from small < 1000 registered list size to large > 20,000 registered list size. There was a mixture of both rural and urban practices .
11North of England Cancer Network Cancer Diagnostic Pathway Audit
Methodology – The Participating PracticesMethodology – The Participating Practices
Participating PracticesDr Cloak and Partners Sunderland
Springwell Medical Group,Sunderland
Glenpark Medical Centre,Gateshead
Bridges Medical PracticeGateshead
Coquet Medical Group, MorpethNorthumberland
Biddlestone Health Group,Newcastle upon Tyne
Lane End SurgeryNewcastle upon Tyne
Harbottle SurgeryNorthumberland
Branch End Surgery, StocksfieldNorthumberland
The Linthorpe SurgeryMiddlesbrough
Havelock Grange PracticeHartlepool
Tennant Street PracticeStockton
Yarm Medical PracticeYarm
Blackhall and Peterlee PracticePeterlee
Jupiter House PracticePeterlee
Station View Health CentreBishop AucklandCo Durham
Murton Medical GroupMurton, SeahamCo Durham
Consett Medical Centre , ConsettCo Durham
Waterloo House SurgeryMillom, Cumbria
Flatt Walks Health CentreWhitehavenCumbria
West Street Practice, AspatriaCumbria
Brunswick House Medical GroupCarlisleCumbria
- - -
North of England Cancer Network Cancer Diagnostic Pathway Audit 12
Methodology – Practice Locations and PopulationMethodology – Practice Locations and Population
Dotted Eyes © Crown copyright and/or database right 2008. All rights reserved. Licence number 100019918
22 Practices from across the NECN agreed to participate in this audit
Commissioning Cluster Participating Practice
Cumbria 4
Durham 5
North of Tyne 5
South of Tyne 4
Tees 4
Total Participating Practice Population approximately 207,000
Total NECN Population = > 3 million
North of England Cancer Network Cancer Diagnostic Pathway Audit 13
Methodology – Tools, Parameters and TimelinesMethodology – Tools, Parameters and Timelines
The Timelines
The Exclusions
The Audit Parameters
The Template
The data fields were developed to:• Determine any relationship between age/gender/ethnicity/communication and access
and the likelihood of urgent referral or diagnosis of cancer• Indicate where health promotion campaigns may encourage earlier attendance• Identify delays in referrals for certain cancers• Identify delays that practice systems may affect onward referral• Identify potential delays in the method or urgency of referral
The Audit, collected data from the period between the 1 April 2009 and the 31 March 2010. Records to be included needed to have demonstrated at least one of the following within the timeframe:• a patient presentation • a patient referral • a specialist appointment
Records of patients diagnosed through screening were excluded as were dyscrasias , pre malignant states and non melanotic carcinoma of the skin
The Audit process started in June 2010 and ran through until the end of October 2010 in which time the Practices were required to submit their completed audit template and their practice meeting /learning event report. Data cleansing, analysis and report development started in September and ran through until Mid November 2010.
14North of England Cancer Network Cancer Diagnostic Pathway Audit
The Audit ProcessThe Audit Process
15North of England Cancer Network Cancer Diagnostic Pathway Audit
Stage 2 – Data Cleansing and AnalysisStage 3 – Individual Practice learning and report submission
Stage 4 - Report development and sign off
Stage 1- Template completion and Submission
Two practices withdrew from the Audit.
The remaining 22 participating Practices met the timelines for template submission - 30/9/10
There was some support required for a few practices during template completion. This was carried out by email or telephone and mainly concerned the functionality of the spreadsheet template.
Support was supplied by external consultants who were commissioned to project manage the process, analyse the data and produce the report.
The Audit ProcessThe Audit Process
Data cleansing was carried out in two parts:Part 1 where all dates were checked and validated.Part 2 where data was checked for logic, completeness and clarity. Where anomalies and or blanks in data was discovered the Practices where asked to recheck and/or to complete selected data fields.
Data analysis was carried out across the consolidated data set for the whole Network. Individual practice analysis and locality analysis was considered problematic due to the limited amount of records in each cohort and the danger of revealing any individual patient record or source.
All practices were asked to consider their audit findings at a Practice meeting and /or learning event.
Each Practice submitted a record of these discussions using a pre prepared template or free text notes or minutes by 31/10/10.
The Practices were required to consider the following for their report:
•Issues from the Audit•Learning from the results•Action taken in the practice
The main themes from these reports were collated and summarised for this report.
An initial draft report was produced for a meeting with the GP Cancer Leads on the 15/10/10.
At this meeting the scope of the analysis was discussed and agreed.
Further development of the report was undertaken and submitted to the Cancer Leads for input on 4/11/10.
The report was finalised on 12 November 2010.
16North of England Cancer Network Cancer Diagnostic Pathway Audit
FindingsFindings
17North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - OverviewFindings - Overview
18North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings – Key Factors Findings – Key Factors
To qualify as a valid record it was agreed that the following key data items had to be 100% complete:•Age•Gender•Ethnicity•Diagnosis•Stage at Diagnosis•Where the patient first presented•Would rapid access to investigations alter case management•Type of referral
The numbers of records for each cancer site ranged from 2 to 105.
For the purposes of this report analysis at cancer site level has been restricted to the 5 sites with >50 records:•Lung•Colorectal•Prostate•Breast•Bladder
To maintain overall effective analysis this has been carried out at Network level only.
19North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Base InformationFindings - Base Information
“Top 5 Cancer Sites” – this colour coding, where relevant, has been used within site specific graphs
20North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Base InformationFindings - Base Information
21North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Base InformationFindings - Base Information
22North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Base InformationFindings - Base Information
23North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Base InformationFindings - Base Information
Is the Patient Housebound?
Lung Colorectal Bladder Breast Prostate
NO 81 80 40 76 83
YES 15 15 6 8 2
Not Known 9 5 6 3 12
Does the Patient have any communication problems?
Lung Colorectal Bladder Breast Prostate
Dementia 2 1 0 1 1
Learning Difficulties 1 0 0 1 0
Mental Health 2 0 2 0 1
Poor Hearing 2 3 2 0 2
Poor Vision 1 3 1 1 1
24North of England Cancer Network Cancer Diagnostic Pathway Audit
Vulnerable Groups
Findings - AttendancesFindings - Attendances
It seems that by far the majority of patients only attend once or twice before being referred to Secondary Care. With regard to the 56 patients with zero attendance the assumption is that these were emergencies or not referred by the practice. However there is insufficient information to arrive at such a conclusion. Of these 56 records, 4 were recorded “Unknown” in terms of the referral type and 25 appear to have been referred by the practice. 9 of the 25 ‘subset’ were referred on the day of attendance, therefore the practices may have recorded these as a zero attendance.
This graph represents 631 records, the remaining 65 records presented insufficient detail on number of attendances to be used in this analysis.
North of England Cancer Network Cancer Diagnostic Pathway Audit 25
Findings - Attendances Findings - Attendances
26North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - AttendancesFindings - Attendances
North of England Cancer Network Cancer Diagnostic Pathway Audit 27
Findings - Referral Details and ProcessesFindings - Referral Details and Processes
28North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Referral Details and ProcessesFindings - Referral Details and Processes
29North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Referral Details and ProcessesFindings - Referral Details and Processes
30North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Referral Details and ProcessesFindings - Referral Details and Processes
Reviewing average number of days between attendance and referral needs to be aligned with the number of records e.g. Vulval shows an average of 66.5 days between attendance and referral. However there are only two records, one with 1 day between attendance and referral and the other with 132 days.
Endometrial Melanoma Breast Oesophageal Testicular Gallbladder Mesothelioma Ovarian Colorectal Unknown Primary Thyroid Oropharyngeal Stomach Leukaemia
Average Days 2.7 6.0 7.9 10.5 11.0 15.0 15.6 15.8 16.4 16.8 19.0 19.4 22.2 25.1
No Records 11 21 87 20 2 6 5 14 100 6 3 7 15 15
Min days 0 0 0 0 8 0 0 0 0 1 1 0 0 0
Max days 22 56 170 40 14 40 61 125 176 40 37 73 99 135
Bladder Pancreatic Prostate Other Renal Liver Cervical Sarcoma Lung Laryngeal Myeloma Lymphoma Brain Vulval
Average Days 27.1 27.3 28.6 29.4 29.5 29.8 37.0 40.5 41.2 45.0 49.1 51.7 56.4 66.5
No Records 52 8 97 32 20 5 4 6 105 7 10 26 10 2
Min days 0 0 0 0 0 0 0 0 0 0 5 0 0 1
Max days 303 114 377 246 185 77 138 127 436 197 167 269 472 132
31North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Referral Details and ProcessesFindings - Referral Details and Processes
The “2 Week” referral option is by far the most common type of referral with more than 50% of all referrals falling into this group. A similar pattern is seen when selecting the ‘Top 5’ cancer sites . The follow page separates out the ‘Top 5’ cancer sites to illustrate the percentage share of type of referral
32North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Referral Details and ProcessesFindings - Referral Details and Processes
33North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Referral Details and ProcessesFindings - Referral Details and Processes
34North of England Cancer Network Cancer Diagnostic Pathway Audit
Days from Referral to First Seen/Investigated by Specialist
All Records Lung Colorectal Bladder Breast Prostate
0-14 days 431 75 63 25 64 60
15 – 21 days 56 3 11 5 9 6
22 – 28 days 33 3 0 8 3 6
29 – 35 days 27 3 4 1 3 6
36 – 42 days 11 2 2 1 1 0
43 + days 48 5 10 3 0 9
Unknown 90 14 10 9 7 10
696 105 100 52 87 97
Findings - DiagnosisFindings - Diagnosis
In this audit it appears that the majority of cases are diagnosed at organ level. Lung being the exception, where a greater percentage appears to be diagnosed at later stages of the disease
35North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Possible Avoidable DelaysFindings - Possible Avoidable Delays
With most cancers, the earlier the diagnosis is made, the better the prognosis. One of the aims of the audit was to identify whether there were any avoidable delays in the patient journey.
A wide range of factors possibly affecting the patient journey were reported. For the purposes of this report these have been categorised within the context of “A Health System” modelled below. 67% of records stated that there was no avoidable delays in the patient journey. Of the total 696 records 128 indicated avoidable delays with a further 67 records recording “Unsure”.
“Health System Model”
Communications Issues
Clinical Decisions and Actions
Patient Decisions and Actions Referral Processes Non SpecificInvestigations and
Reporting
Factors relating to the clinical decisions and actions made in both primary and secondary care
Factors relating to poor or inappropriate communication that could have occurred at any stage within the patient journey
Factors relating to the failure, delay or reporting of investigations including relevance and timeliness
Factors relating to decisions and actions made by the patient
Factors relating to aspects of referral – such as timeliness, appropriateness and the referral protocols themselves
Some comments were too vague or unique to categorise
72 Records
17Records
27 Records
45 Records
36Records
12Records
36North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Possible Avoidable DelayFindings - Possible Avoidable Delay
The above presents the “Health System Model” categories across all records and shows a summary of comments made regarding possible avoidable delays. In indicating possible delays 195 records stated “Yes” or “Unsure”. It should be noted that some records recorded “No” but still provided comments. All comments have been included in this categorisation. 487 comments have been reflected in this section.
37North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Possible Avoidable DelayFindings - Possible Avoidable Delay
38North of England Cancer Network Cancer Diagnostic Pathway Audit
Findings - Possible Avoidable DelayFindings - Possible Avoidable Delay
39North of England Cancer Network Cancer Diagnostic Pathway Audit
Practice Learnings and ActionsPractice Learnings and Actions
40North of England Cancer Network Cancer Diagnostic Pathway Audit
Issues Learning's Actions
Some Practices identified changes to specific process and/or administrative procedures to improve communication. Examples of these include:•Regular forums where suspect cases can be discussed. These discussions would take place prior to referral and help the decision making processes around case management and the referral ;• ‘red flagging’ suspected cancer on Practice systems to ensure all clinicians are aware of potential diagnosis.The majority of Practices highlighted issues that had not been clear to them before the audit . Examples include: •Prostate Cancer protocols required review •Repeat chest x-ray for suspected lung cancer required further thought and action• The 2 week referral criteria did not always fit a patient presentation • 2 week referrals were being seen within the timeline but patients often waited a long time for further investigations •Co morbidity often masked underlying cancer • Negative investigation results delayed diagnosis
By far the most important ‘learning’ the practices described was that they were required to be far more vigilant in their suspicions of cancer even when the clinical presentation did not ‘quite fit’ , the initial investigations were negative and/or the patient had co morbid disease that may mask an underlying cancer. Practices described the potential to establish effective training and development, case review and significant event audit to ensure more effective and informed vigilance.The other ‘learning’ that stood out was that communication within the practice was vital. To address this the following developments were highlighted:• Red flagging systems to identify potential cancer cases• Forums for complex case discussions• Standardisation of patient review systems and operational practices to ensure that investigations are carried out appropriately, consistently and timely. The majority of the practices reported that the audit had been beneficial and some practices planned to repeat the audit in one year.
Practice Learning and ActionsPractice Learning and Actions
All the practices reported some actions to improve the current patient journey in primary care. The following are the key themed actions reported:• Forums for internal discussions• Improving system coding/flagging• Reviewing internal investigative protocols e.g. Prostate• Lowering threshold for investigations e.g. Chest X-rays for smokers; further investigations for anaemia.• Improving teaching about diligence in complex cases • Significant event audit on complex cases• Improve systems to track results• Increase the amount of routine weighing of patients
North of England Cancer Network Cancer Diagnostic Pathway Audit 41
RecommendationsRecommendations
42North of England Cancer Network Cancer Diagnostic Pathway Audit
RecommendationsRecommendations
North of England Cancer Network Cancer Diagnostic Pathway Audit 43
AcknowledgementsAcknowledgements
44North of England Cancer Network Cancer Diagnostic Pathway Audit
AcknowledgementsAcknowledgements
Name Organisation email
Dr Duncan Leith NECN – Cancer Lead and Chair of the Primary Care Group [email protected]
Dr Jonathan Berry NECN GP Cancer Lead [email protected]
Dr Robin Armstrong NECN GP Cancer Lead [email protected]
Dr Henry Choi NECN GP Cancer Lead [email protected]
Dr Joan Bryson NECN GP Cancer Lead [email protected]
Dr Relton Cummings NECN GP Cancer Lead [email protected]
Susan Collins Cancer Services Officer, NHS Cumbria [email protected]
Professor Greg Rubin Wolfson Unit, Durham University [email protected]
Suzanne Thompson NECN Cancer Modernisation Manager [email protected]
Joanne Preston NECN Service Improvement Facilitator [email protected]
Linda Wintersgill Information and Audit Manager NECN [email protected]
All Participating Practices and their staff
45North of England Cancer Network Cancer Diagnostic Pathway Audit
46North of England Cancer Network Cancer Diagnostic Pathway Audit